DY
BMEZ icon

Dowling & Yahnke’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Dowling & Yahnke’s Portfolio BMEZ Stock Details BMEZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$149K Buy
+10,000
New +$165K 0.01% 358

Other funds holding BMEZ

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
QC
Quantedge Capital Singapore $183M AUM 37.27% 1-Year Est. Return
COLIM
City of London Investment Management London, United Kingdom $1.38B AUM 42.43% 1-Year Est. Return

Dowling & Yahnke's BMEZ Position: Q3 2022 in Review

Dowling & Yahnke opened a new position in BlackRock Health Sciences Trust II (BMEZ) in Q3 2022: 10,000 shares worth $149K. The stake represents 0.01% of the portfolio and ranks #358 among its holdings.

75 funds tracked by Wall St. Rank hold BMEZ as of Q3 2022.

  • Dowling & Yahnke held 10,000 shares of BlackRock Health Sciences Trust II worth $149K as of Q3 2022.
  • BlackRock Health Sciences Trust II was a new Dowling & Yahnke position in Q3 2022.
  • BlackRock Health Sciences Trust II made up 0.01% of Dowling & Yahnke's portfolio in Q3 2022, its #358 holding.
  • 75 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.